{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:55:01Z","timestamp":1795107301168,"version":"4.10.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01480-y","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T09:02:04Z","timestamp":1754989324000},"page":"473-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery"],"prefix":"10.1038","volume":"10","author":[{"given":"Saijuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-3075","authenticated-orcid":false,"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiudao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haokun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-8575","authenticated-orcid":false,"given":"Changrui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongrui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-9816","authenticated-orcid":false,"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0183-5574","authenticated-orcid":false,"given":"Yuming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-4317","authenticated-orcid":false,"given":"Zi Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9155-9883","authenticated-orcid":false,"given":"Yuxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"1480_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2029392","volume":"384","author":"EB Esrick","year":"2021","unstructured":"Esrick, E. B. et al. Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. N. Engl. J. Med. 384, 205\u2013215 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1480_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N. Engl. J. Med. 384, 252\u2013260 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1480_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","volume":"28","author":"B Fu","year":"2022","unstructured":"Fu, B. et al. CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia. Nat. Med. 28, 1573\u20131580 (2022).","journal-title":"Nat. Med."},{"key":"1480_CR4","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3390\/cells11111843","volume":"11","author":"P Germino-Watnick","year":"2022","unstructured":"Germino-Watnick, P. et al. Hematopoietic stem cell gene-addition\/editing therapy in sickle cell disease. Cells 11, 1843 (2022).","journal-title":"Cells"},{"key":"1480_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","volume":"18","author":"M Cavazzana","year":"2019","unstructured":"Cavazzana, M., Bushman, F. D., Miccio, A., Andre-Schmutz, I. & Six, E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat. Rev. Drug Discov. 18, 447\u2013462 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1480_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","volume":"22","author":"G Ferrari","year":"2021","unstructured":"Ferrari, G., Thrasher, A. J. & Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216\u2013234 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"1480_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/pr.2011.57","volume":"71","author":"T Daikeler","year":"2012","unstructured":"Daikeler, T., Tichelli, A. & Passweg, J. Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases. Pediatr. Res. 71, 439\u2013444 (2012).","journal-title":"Pediatr. Res."},{"key":"1480_CR8","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/s41591-022-01934-9","volume":"28","author":"A Aiuti","year":"2022","unstructured":"Aiuti, A., Pasinelli, F. & Naldini, L. Ensuring a future for gene therapy for rare diseases. Nat. Med. 28, 1985\u20131988 (2022).","journal-title":"Nat. Med."},{"key":"1480_CR9","first-page":"2085","volume":"141","author":"C Li","year":"2023","unstructured":"Li, C. et al. In vivo HSC prime editing rescues sickle cell disease in a mouse model. Blood 141, 2085\u20132099 (2023).","journal-title":"Blood"},{"key":"1480_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1172\/JCI122836","volume":"129","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. J. Clin. Invest. 129, 598\u2013615 (2019).","journal-title":"J. Clin. Invest."},{"key":"1480_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.hoc.2017.06.001","volume":"31","author":"M Richter","year":"2017","unstructured":"Richter, M. et al. In vivo hematopoietic stem cell transduction. Hematol. Oncol. Clin. North Am. 31, 771\u2013785 (2017).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"1480_CR12","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.7150\/thno.77259","volume":"12","author":"HN Jung","year":"2022","unstructured":"Jung, H. N., Lee, S. Y., Lee, S., Youn, H. & Im, H. J. Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging. Theranostics 12, 7509\u20137531 (2022).","journal-title":"Theranostics"},{"key":"1480_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"1480_CR14","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806\u20132827 (2022).","journal-title":"Cell"},{"key":"1480_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong, Y., Lin, Y., Wei, T. & Cheng, Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv. Mater. 35, e2303261 (2023).","journal-title":"Adv. Mater."},{"key":"1480_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"1480_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","volume":"39","author":"T Rothgangl","year":"2021","unstructured":"Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. 39, 949\u2013957 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR18","doi-asserted-by":"publisher","first-page":"e2116271119","DOI":"10.1073\/pnas.2116271119","volume":"119","author":"M Qiu","year":"2022","unstructured":"Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR19","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 23, 2938\u20132944 (2023).","journal-title":"Nano Lett."},{"key":"1480_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/pharmaceutics13101675","volume":"13","author":"MM Zak","year":"2021","unstructured":"Zak, M. M. & Zangi, L. Lipid nanoparticles for organ-specific mRNA therapeutic delivery. Pharmaceutics 13, 1675 (2021).","journal-title":"Pharmaceutics"},{"key":"1480_CR21","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1039\/D3TB00649B","volume":"11","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Golubovic, A., Xu, S., Pan, A. & Li, B. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery. J. Mater. Chem. B 11, 6527\u20136539 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"1480_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"1480_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"1480_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059890","volume":"8","author":"R Kurita","year":"2013","unstructured":"Kurita, R. et al. Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS ONE 8, e59890 (2013).","journal-title":"PLoS ONE"},{"key":"1480_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nm.4170","volume":"22","author":"EA Traxler","year":"2016","unstructured":"Traxler, E. A. et al. A genome-editing strategy to treat \u03b2-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. Nat. Med. 22, 987\u2013990 (2016).","journal-title":"Nat. Med."},{"key":"1480_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41588-021-00861-8","volume":"53","author":"L Cheng","year":"2021","unstructured":"Cheng, L. et al. Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression. Nat. Genet. 53, 869\u2013880 (2021).","journal-title":"Nat. Genet."},{"key":"1480_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34601-6","volume":"8","author":"J Yen","year":"2018","unstructured":"Yen, J. et al. TRIAMF: a new method for delivery of Cas9 ribonucleoprotein complex to human hematopoietic stem cells. Sci. Rep. 8, 16304 (2018).","journal-title":"Sci. Rep."},{"key":"1480_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","volume":"25","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat. Med. 25, 776\u2013783 (2019).","journal-title":"Nat. Med."},{"key":"1480_CR30","doi-asserted-by":"publisher","first-page":"e65421","DOI":"10.7554\/eLife.65421","volume":"11","author":"NS Ravi","year":"2022","unstructured":"Ravi, N. S. et al. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. eLife 11, e65421 (2022).","journal-title":"eLife"},{"key":"1480_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-2-206","volume":"4","author":"J Kaczynski","year":"2003","unstructured":"Kaczynski, J., Cook, T. & Urrutia, R. Sp1- and Kruppel-like transcription factors. Genome Biol. 4, 206 (2003).","journal-title":"Genome Biol."},{"key":"1480_CR32","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1128\/MCB.19.8.5504","volume":"19","author":"A Doetzlhofer","year":"1999","unstructured":"Doetzlhofer, A. et al. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell. Biol. 19, 5504\u20135511 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"1480_CR33","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1073\/pnas.0502041102","volume":"102","author":"D Feng","year":"2005","unstructured":"Feng, D. & Kan, Y. W. The binding of the ubiquitous transcription factor Sp1 at the locus control region represses the expression of beta-like globin genes. Proc. Natl Acad. Sci. USA 102, 9896\u20139900 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2014.12.005","volume":"4","author":"BE McIntosh","year":"2015","unstructured":"McIntosh, B. E. et al. Nonirradiated NOD,B6.SCID Il2r\u03b3\u2212\/\u2212KitW41\/W41 (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Rep. 4, 171\u2013180 (2015).","journal-title":"Stem Cell Rep."},{"key":"1480_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.omtm.2016.12.009","volume":"4","author":"K-H Chang","year":"2017","unstructured":"Chang, K.-H. et al. Long-term engraftment and fetal globin induction upon BCL11A gene editing in bone-marrow-derived CD34+ hematopoietic stem and progenitor cells. Mol. Ther. Methods Clin. Dev. 4, 137\u2013148 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1480_CR36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.celrep.2016.09.092","volume":"17","author":"MC Gundry","year":"2016","unstructured":"Gundry, M. C. et al. Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR\/Cas9. Cell Rep. 17, 1453\u20131461 (2016).","journal-title":"Cell Rep."},{"key":"1480_CR37","doi-asserted-by":"publisher","first-page":"eabj6901","DOI":"10.1126\/sciadv.abj6901","volume":"8","author":"J Han","year":"2022","unstructured":"Han, J. et al. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy. Sci. Adv. 8, eabj6901 (2022).","journal-title":"Sci. Adv."},{"key":"1480_CR38","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR39","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","volume":"16","author":"J Kim","year":"2022","unstructured":"Kim, J. et al. Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation. ACS Nano 16, 14792\u201314806 (2022).","journal-title":"ACS Nano"},{"key":"1480_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215711120","volume":"120","author":"PPG Guimar\u00e3es","year":"2023","unstructured":"Guimar\u00e3es, P. P. G. et al. In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy. Proc. Natl Acad. Sci. USA 120, e2215711120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).","journal-title":"Nat. Commun."},{"key":"1480_CR42","first-page":"280","volume":"7","author":"B Li","year":"2023","unstructured":"Li, B. et al. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat. Biomed. Eng. 7, 280 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"1480_CR43","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1021\/acs.accounts.1c00500","volume":"54","author":"M Qiu","year":"2021","unstructured":"Qiu, M., Li, Y., Bloomer, H. & Xu, Q. Developing biodegradable lipid nanoparticles for intracellular mRNA delivery and genome editing. Acc. Chem. Res. 54, 4001\u20134011 (2021).","journal-title":"Acc. Chem. Res."},{"key":"1480_CR44","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1182\/bloodadvances.2020003714","volume":"5","author":"C Li","year":"2021","unstructured":"Li, C. et al. Single-dose MGTA-145\/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice. Blood Adv. 5, 1239\u20131249 (2021).","journal-title":"Blood Adv."},{"key":"1480_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357\u20131364 (2010).","journal-title":"Mol. Ther."},{"key":"1480_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301377","volume":"10","author":"D Tarab-Ravski","year":"2023","unstructured":"Tarab-Ravski, D. et al. Delivery of therapeutic RNA to the bone marrow in multiple myeloma using CD38-targeted lipid nanoparticles. Adv. Sci. 10, e2301377 (2023).","journal-title":"Adv. Sci."},{"key":"1480_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/nat.2018.0734","volume":"28","author":"R Jain","year":"2018","unstructured":"Jain, R. et al. MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct. Nucleic Acid Ther. 28, 285\u2013296 (2018).","journal-title":"Nucleic Acid Ther."},{"key":"1480_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"1480_CR49","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/pharmaceutics15031009","volume":"15","author":"A Yavuz","year":"2023","unstructured":"Yavuz, A. et al. DLin-MC3-containing mRNA lipid nanoparticles induce an antibody Th2-biased immune response polarization in a delivery route-dependent manner in mice. Pharmaceutics 15, 1009 (2023).","journal-title":"Pharmaceutics"},{"key":"1480_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.stem.2015.05.003","volume":"17","author":"EM Pietras","year":"2015","unstructured":"Pietras, E. M. et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell 17, 35\u201346 (2015).","journal-title":"Cell Stem Cell"},{"key":"1480_CR51","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nnano.2012.207","volume":"7","author":"MP Monopoli","year":"2012","unstructured":"Monopoli, M. P., Aberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7, 779\u2013786 (2012).","journal-title":"Nat. Nanotechnol."},{"key":"1480_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR53","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1039\/C8NR09855G","volume":"11","author":"D Chen","year":"2019","unstructured":"Chen, D., Ganesh, S., Wang, W. & Amiji, M. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles. Nanoscale 11, 8760\u20138775 (2019).","journal-title":"Nanoscale"},{"key":"1480_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16248-y","volume":"11","author":"L Miao","year":"2020","unstructured":"Miao, L. et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat. Commun. 11, 2424 (2020).","journal-title":"Nat. Commun."},{"key":"1480_CR55","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3390\/cells9122717","volume":"9","author":"F Wirth","year":"2020","unstructured":"Wirth, F., Lubosch, A., Hamelmann, S. & Nakchbandi, I. A. Fibronectin and its receptors in hematopoiesis. Cells 9, 2717 (2020).","journal-title":"Cells"},{"key":"1480_CR56","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1111\/j.1538-7836.2010.04072.x","volume":"8","author":"J Koo","year":"2010","unstructured":"Koo, J. et al. Evaluation of fibrinogen self-assembly: role of its \u03b1C region. J. Thromb. Haemost. 8, 2727\u20132735 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"1480_CR57","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/bm2015976","volume":"13","author":"J Koo","year":"2012","unstructured":"Koo, J. et al. Control of anti-thrombogenic properties: surface-induced self-assembly of fibrinogen fibers. Biomacromolecules 13, 1259\u20131268 (2012).","journal-title":"Biomacromolecules"},{"key":"1480_CR58","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1021\/ja107583h","volume":"133","author":"MP Monopoli","year":"2011","unstructured":"Monopoli, M. P. et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133, 2525\u20132534 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"1480_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11427-018-9402-9","volume":"62","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR\/Cas systems. Sci. China Life Sci. 62, 1\u20137 (2019).","journal-title":"Sci. China Life Sci."},{"key":"1480_CR60","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J. S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1480_CR61","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1182\/bloodadvances.2019000820","volume":"3","author":"JY M\u00e9tais","year":"2019","unstructured":"M\u00e9tais, J. Y. et al. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. Blood Adv. 3, 3379\u20133392 (2019).","journal-title":"Blood Adv."},{"key":"1480_CR62","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1021\/jacs.2c12893","volume":"145","author":"KL Swingle","year":"2023","unstructured":"Swingle, K. L. et al. Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy. J. Am. Chem. Soc. 145, 4691\u20134706 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"1480_CR63","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"1480_CR64","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1480_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger Sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"1480_CR66","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1480_CR67","doi-asserted-by":"publisher","first-page":"21.29.1","DOI":"10.1002\/0471142727.mb2129s109","volume":"109","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.1\u201321.29.9 (2015).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"1480_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1929-3","volume":"21","author":"F Yan","year":"2020","unstructured":"Yan, F., Powell, D. R., Curtis, D. J. & Wong, N. C. From reads to insight: a hitchhiker\u2019s guide to ATAC-seq data analysis. Genome Biol. 21, 22 (2020).","journal-title":"Genome Biol."},{"key":"1480_CR69","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1038\/s41596-020-0373-x","volume":"15","author":"HS Kaya-Okur","year":"2020","unstructured":"Kaya-Okur, H. S., Janssens, D. H., Henikoff, J. G., Ahmad, K. & Henikoff, S. Efficient low-cost chromatin profiling with CUT&Tag. Nat. Protoc. 15, 3264\u20133283 (2020).","journal-title":"Nat. Protoc."},{"key":"1480_CR70","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1480_CR71","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1480_CR72","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"1480_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf4398","volume":"7","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Sci. Adv. 7, eabf4398 (2021).","journal-title":"Sci. Adv."},{"key":"1480_CR74","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","volume":"121","author":"MJ Kiel","year":"2005","unstructured":"Kiel, M. J. et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109\u20131121 (2005).","journal-title":"Cell"},{"key":"1480_CR75","unstructured":"Wang, Q. D. mRNA\u2011HSCedit [Computer software]. GitHub https:\/\/github.com\/wqiudao\/mRNA-HSCedit (2021)."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01480-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:08:41Z","timestamp":1774415321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01480-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":75,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01480-y","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Lu, Z.J.W. and Y.W. are scientific co-founders at YolTech Therapeutics. D.X., W.R., Y.G., H.Z. and C.F. are employees of YolTech Therapeutics. YolTech Therapeutics has filed patents (CN114989182A, CN116162071A, PCT\/CN2023\/100791, PCT\/CN2023\/100823 and PCT\/CN2023\/106421) on the technology described in this paper. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}